Researchers create personalized organoid models for rare spinal cancer
A new study adds to a growing body of evidence that organoids — lab-grown collections of cells that mimic a patient’s tumor — are a promising avenue for drug discovery to improve outcomes in patients with cancer, particularly rare cancers for which clinical data on drug effectiveness is often lacking.
Materials provided by University of California – Los Angeles Health Sciences. Note: Content may be edited for style and length.
Source link aaaaa